Form 4 for BIAF bioAffinity Technologies, Inc.
Accepted 2024-06-14 00:00:00 ET · period of report 2024-06-12 · accession 0001493152-24-023992 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-14 | 2024-06-12 | BIAF | Anderson Robert A. | Dir | A - Grant | $0.00 | +8,296 | 130.2K | +7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-12 | A | A | 8,296 | $0.00 | 130,152 | D | — | — | (F1) Grant of restricted shares of common stock, par value $0.007 per share, that vest immediately. |